Mark Smith, Finch Therapeutics CEO
One week after Takeda walked away, Finch faces second round of layoffs, pipeline pruning
Finch may be an inch underground at this point.
Somerville, MA-based Finch Therapeutics has had a rough year, starting with the FDA slapping a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
